Promising New Antifungal Treatment Targeting Chorismate Synthase from <i>Paracoccidioides brasiliensis</i>

Franciele Abigail Vilugron Rodrigues-Vendramini, Cidnei Marschalk, Marina Toplak, Peter Macheroux, Patricia Mendonca, Terezinha Inez Estivalet Svidzinski, Flávio Augusto Vicente Seixas, Érika Seki Kioshima

Antimicrobial Agents and Chemotherapy · 2018 · 33 citations · 48 references

DOIFull text

Open access

Concepts

Abstract

) of 47 ± 5 μM. As expected, CP1 showed no toxicity in three cell lines. On the other hand, CP1 reduced the fungal burden in lungs from treated mice, similar to itraconazole. In addition, histopathological analysis showed that animals treated with CP1 displayed less lung tissue infiltration, fewer yeast cells, and large areas with preserved architecture. Therefore, CP1 was able to control PCM in mice with a lower inflammatory response and is thus a promising candidate and lead structure for the development of drugs useful in PCM treatment.

References

48